ARAV lead gap this morning from 6.6 to a H@29.6.
Post# of 63696
NEWS:
Aravive Reports Positive Data Supporting Relationship Between AVB-500 Levels, Anti-Tumor Activity and Progression Free Survival in Women with Ovarian Cancer
IPO from 4/2015 H (scaled @ $220) Low 3.3 and IH Board generated on 10/29/2017 - After a gap down from 15-10.
Read More: https://investorshangout.com/recentnews/ARAV#ixzz65p8lFAOT
I (Znewcar1) do not provide personal investment advice and I am not a qualified licensed investment advisor. I am an amateur investor.
All information found here, including any ideas, opinions, views, predictions, forecasts, commentaries, suggestions, or stock picks, expressed or implied herein, are for informational, entertainment or educational purposes only and should not be construed as personal investment advice. While the information provided is believed to be accurate, it may include errors or inaccuracies.
I will not and cannot be held liable for any actions you take as a result of anything you read here.